Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Katherine Knorr(Io Therapeutics (United States)), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
Cited by 21
Related Papers
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
|Nature Medicine|2019|226
MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors
|Cell Death and Differentiation|2015|98
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
|Cancer Discovery|2022|36